A clinical study shows that a symptom-based treatment for babies with neonatal opioid withdrawal syndrome (NOWS)—a highly ...

This is the second post in a series on non-medication approaches for alcohol and drug abuse. Opioid addiction is a public health crisis in the U.S. It is estimated that as many as 36 million Americans ...

It's time to "move beyond the all or nothing" scheduled tapering approach, researchers say ...

CINCINNATI (WKRC) - A new and improved way to care for babies born suffering from addiction withdrawal symptoms could be coming, according to a new trial. Several local hospitals, including UC Medical ...

A National Institutes of Health (NIH)-funded clinical study shows that a symptom-based treatment for babies with neonatal ...

Lofexidine is administered during the period of peak withdrawal symptoms. The Food and Drug Administration (FDA) has approved Lofexidine Tablets 0.18mg, the first generic of Lucemyra. Lofexidine is a ...

EVERETT, Wash. — The Everett Fire Department’s Emergency Medical Services Division (EMS) has launched a new pilot programto allow paramedics to administer buprenorphine, to help with opiate withdrawal ...

Officials in Hennepin and Ramsey County are using buprenorphine, a medication to treat opiate withdrawals symptoms that affect a growing number of Minnesotans. More cities are taking notice. As a ...

Studies show that ibogaine can be effective for short-term opioid addiction treatment, especially reducing drug cravings and some withdrawal symptoms.